A KFF Health News database tracks campaign donations from drugmakers over the past 10 years.
KHN’s ‘What the Health?’: FDA Takes Center Stage
Congress is set to start its once-every-five-years review of the law that authorizes user fees to finance the hiring of personnel to speed the FDA review of drugs. The periodic renewals of “PDUFA” also give lawmakers a chance to make other changes to the agency at the hub of the pandemic. Meanwhile, the FDA could also find itself at the center of the abortion debate and a controversial new medication to treat Alzheimer’s disease. Anna Edney of Bloomberg News, Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico, and Sarah Karlin-Smith of the Pink Sheet join KHN’s Julie Rovner to discuss these issues and more.
Vaccine Wars Ignite in California as Lawmakers Seek Stronger Laws
Anti-vaccination activists say California’s Democratic lawmakers are helping strengthen their movement nationally by pushing for tougher vaccine requirements — without exemptions for religious or personal beliefs. But a new pro-vaccine lobbying force is vowing to fight back.
California Ballot Will Be Heavy on Health Care
In the Nov. 8 general election, California voters will consider overturning the state’s flavored tobacco ban and hiking medical malpractice awards. Other proposals to decriminalize psychedelic mushrooms, target dialysis clinics and boost public health funding could also be on the ballot, along with a plan to limit business and school closures during public health emergencies.
South Dakota Voters to Decide Medicaid Expansion
Despite state Republican leaders’ rigid opposition to expanding the health program designed for low-income residents, advocates successfully gathered enough signatures to get the measure on the fall ballot.
It’s Not Just Covid: Recall Candidates Represent Markedly Different Choices on Health Care
Those seeking to replace California Gov. Gavin Newsom in Tuesday’s recall election disagree with him on more than mask and vaccine mandates. The conservative candidates tend to favor free-market solutions over Newsom’s expansion of publicly funded health coverage.
Voters in Tight Recall Race Sound Off on California Gov. Newsom’s Covid Leadership
Democratic Gov. Gavin Newsom’s pandemic policies are effectively on California’s Sept. 14 recall ballot — and the electorate views them with a mix of resentment, gratitude and disillusionment.
Health Issues Carried Weight on the Campaign Trail. What Could Biden Do in His First 100 Days?
KHN has teamed up with PolitiFact to track what becomes of President Joe Biden’s 2020 campaign promises over the next four years. As he moves into the West Wing, what are his chances of making progress on health care?
Only a Smokescreen? Big Tobacco Stands Down as Colorado and Oregon Hike Cigarette Taxes
After spending tens of millions of dollars to oppose past efforts, Altria didn’t oppose Colorado’s tobacco tax initiative and could benefit from the law’s minimum-price provision.
Biden’s First Order of Business May Be to Undo Trump’s Policies, but It Won’t Be Easy
President Donald Trump made substantial changes to the nation’s health care system using executive branch authority. But reversing policies that Democrats oppose would take time and personnel resources, competing with other priorities of the new administration.
Democrats Are Running Hard on Health Care in Georgia’s Senate Runoffs. Republicans? Not So Much.
Democrats are treating health care as a more critical issue than their Republican counterparts in Georgia’s two U.S. Senate runoffs. It’s a strategy they hope will woo independents and motivate base voters. The results will determine which party controls the chamber during the first years of the Biden administration.
As Biden Gets Sworn In, White House Will Get Scrubbed Down
Fears about lingering coronavirus at the White House are prompting a massive disinfection initiative before the Bidens move in.
This Health Care Magnate Wants to Fix Democracy, Starting in Colorado
Kent Thiry, the former CEO of dialysis giant DaVita, has clear ideas about how democracy should work. By backing ballot measures in Colorado, he’s shaping the power of voters in that state.
Dialysis Industry Spends Millions, Emerges as Power Player in California Politics
Over the past four years, the dialysis industry has spent $233 million on both political offense and defense in California. Most of it went toward protecting its revenues against ballot initiatives, but the industry also strategically worked the corridors of the state Capitol.
As More Red States Legalize Marijuana, Some Officials Try to Nip It in the Bud
Recreational marijuana may face resistance from GOP-dominated state governments despite being voted into law in Montana, South Dakota and Arizona.
Becerra, un candidato para el HHS con habilidad política pero sin experiencia en salud
La experiencia de Xavier Becerra no proviene de la salud o la ciencia. Pero tiene una larga trayectoria política ligada a las luchas por la equidad en salud.
In Becerra, an HHS Nominee With Political Skill But No Front-Line Health Experience
Despite his lack of front-line experience, Democrats see the California attorney general as an important ally to shepherd a progressive agenda on the Affordable Care Act, Medicaid, reproductive health services and immigration.
Senate Republicans Throw the Brakes on Timing for Becerra Hearings
Republican spokespeople for the committees responsible for vetting Health and Human Services nominations said the Senate may not hold hearings on California Attorney General Xavier Becerra, President-elect Joe Biden’s pick to lead the department, until the Senate approves committee assignments for the new Congress. That could delay the start of the process.
KHN’s ‘What the Health?’: Transition Interrupted
Former Vice President Joe Biden is now the president-elect nearly everywhere but inside the Trump administration, where the president refuses to concede and has ordered officials not to begin a formal transition. That is a particular problem for health care as the COVID-19 pandemic surges. Meanwhile, there’s good news on the vaccine front, but it’s unlikely one will arrive by winter. And the ACA was back before the Supreme Court — again. Joanne Kenen of Politico, Stephanie Armour of The Wall Street Journal and Shefali Luthra of the 19th News join KHN’s Julie Rovner to discuss these issues and more. Plus, for extra credit, the panelists recommend their favorite health stories of the week they think you should read, too.
Biden Plan to Lower Medicare Eligibility Age to 60 Faces Hostility From Hospitals
Hospitals, a potent political force, fear lowering the eligibility age will cost them billions of dollars in revenue because federal reimbursements are lower than private insurers’.
